1. Home
  2. AAME vs GANX Comparison

AAME vs GANX Comparison

Compare AAME & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAME
  • GANX
  • Stock Information
  • Founded
  • AAME 1968
  • GANX 2017
  • Country
  • AAME United States
  • GANX United States
  • Employees
  • AAME N/A
  • GANX N/A
  • Industry
  • AAME Life Insurance
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAME Finance
  • GANX Health Care
  • Exchange
  • AAME Nasdaq
  • GANX Nasdaq
  • Market Cap
  • AAME 34.9M
  • GANX 31.5M
  • IPO Year
  • AAME N/A
  • GANX 2021
  • Fundamental
  • Price
  • AAME $1.58
  • GANX $1.08
  • Analyst Decision
  • AAME
  • GANX Strong Buy
  • Analyst Count
  • AAME 0
  • GANX 4
  • Target Price
  • AAME N/A
  • GANX $8.25
  • AVG Volume (30 Days)
  • AAME 3.9K
  • GANX 315.7K
  • Earning Date
  • AAME 08-06-2024
  • GANX 08-08-2024
  • Dividend Yield
  • AAME 2.50%
  • GANX N/A
  • EPS Growth
  • AAME N/A
  • GANX N/A
  • EPS
  • AAME N/A
  • GANX N/A
  • Revenue
  • AAME $187,521,000.00
  • GANX N/A
  • Revenue This Year
  • AAME N/A
  • GANX $1,009.10
  • Revenue Next Year
  • AAME N/A
  • GANX N/A
  • P/E Ratio
  • AAME N/A
  • GANX N/A
  • Revenue Growth
  • AAME 2.74
  • GANX N/A
  • 52 Week Low
  • AAME $1.49
  • GANX $1.05
  • 52 Week High
  • AAME $3.00
  • GANX $5.33
  • Technical
  • Relative Strength Index (RSI)
  • AAME 41.56
  • GANX 32.30
  • Support Level
  • AAME $1.58
  • GANX $1.05
  • Resistance Level
  • AAME $1.77
  • GANX $1.24
  • Average True Range (ATR)
  • AAME 0.07
  • GANX 0.08
  • MACD
  • AAME 0.00
  • GANX 0.03
  • Stochastic Oscillator
  • AAME 22.32
  • GANX 8.57

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts. It also provides tailored business automobile insurance coverage, on a multi-year contract basis, to state governments and local municipalities, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance. It earns revenue from the collection of premiums and investment income.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Share on Social Networks: